2[125I]Iodomelatonin binding sites in guinea pig platelets

Area of Science:

• Pharmacology
• Biochemistry
• Neuroendocrinology

Background:

• Melatonin receptors are implicated in various physiological processes.
• Characterization of melatonin binding sites in different species and tissues is crucial for understanding melatonin's actions.
• Previous studies reported nanomolar [3H]melatonin binding sites in human platelets.

Purpose of the Study:

• To characterize 2[125I]iodomelatonin binding sites in guinea pig platelet membranes.
• To investigate the pharmacological and physiological relevance of these binding sites.
• To compare these findings with previously reported melatonin binding sites.

Main Methods:

• Radioligand binding assays using 2[125I]iodomelatonin.
• Saturation and competition binding studies.
• Guanine nucleotide sensitivity assays.
• Immunoblotting with anti-MT(1) IgG.
• Assessment of melatonin's effect on cyclic AMP accumulation.
• Studies on platelet aggregation.

Main Results:

• Identified saturable, reversible, high-affinity (picomolar) 2[125I]iodomelatonin binding sites (Bmax: 11.8 fmol/mg protein).
• Demonstrated G-protein coupling of these sites.
• Observed diurnal variation in binding density, abolished under constant light.
• Found that physiological melatonin potentiated, while pharmacological levels inhibited, platelet aggregation.

Conclusions:

• Guinea pig platelets possess unique, high-affinity G-protein coupled melatonin binding sites.
• These sites differ pharmacologically from human platelet melatonin binding sites.
• Melatonin binding sites in platelets may play a role in regulating platelet function.